DRUG AFFINITIES FOR THE AGONIST AND ANTAGONIST STATES OF THE OPIOID RECEPTOR

被引：5
|
作者：
CHENEY, BV
LAHTI, RA
BARSUHN, C
机构：
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1982年 / 77卷 / 04期
关键词：
D O I：
10.1016/0014-2999(82)90127-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 50 条
  • [21] Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands
    Mosberg, Henry I.
    Yeomans, Larisa
    Harland, Aubrie A.
    Bender, Aaron M.
    Sobczyk-Kojiro, Katarzyna
    Anand, Jessica P.
    Clark, Mary J.
    Jutkiewicz, Emily M.
    Traynor, John R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) : 2139 - 2149
  • [22] Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
    Levy-Cooperman, N.
    McIntyre, G.
    Bonifacio, L.
    McDonnell, M.
    Davenport, J. M.
    Covington, P. S.
    Dove, L. S.
    Sellers, E. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 359 (03): : 471 - 481
  • [23] Longitudinal Measurement of Opioid Receptor Occupancy from Sustained Release Naltrexone: Comparison of Agonist, Partial Agonist and Antagonist Opioid Receptor Radiotracers in Rats
    Reed, B.
    Schoultz, B.
    Coello, C.
    Hjornevik, T.
    Lindblom, I.
    Henriksen, G.
    Willoch, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S266 - S266
  • [24] Opioid dipeptide derivatives with a mixed μ agonist δ antagonist, partial μ agonist δ antagonist or μ agonist partial δ agonist profile
    Schiller, PW
    Weltrowska, G
    Nguyen, TMD
    Wilkes, BC
    Lemieux, C
    Chung, NN
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 229 - 230
  • [25] Combining an oral opioid-receptor agonist and the antagonist naloxone: A smart drug design that removes some but not all adverse effects of the opioid analgesic
    Breivik, Harald
    Werner, Mads U.
    SCANDINAVIAN JOURNAL OF PAIN, 2014, 5 (02) : 72 - 74
  • [26] Opioid Agonist and Antagonist Therapies Prevent Opioid Relapse
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (04): : 333 - 333
  • [27] EFFECT OF HOT PLATE TEMPERATURE ON OPIOID AGONIST-ANTAGONIST DRUG ACTIVITY
    ZIMET, PO
    WYNN, PL
    FORD, R
    RUDO, FG
    JOURNAL OF DENTAL RESEARCH, 1986, 65 (04) : 478 - 478
  • [28] CHANGES IN PITUITARY SECRETION INDUCED BY AN AGONIST-ANTAGONIST OPIOID DRUG, BUPRENORPHINE
    ROLANDI, E
    MARABINI, A
    FRANCESCHINI, R
    MESSINA, V
    BONGERA, P
    BARRECA, T
    ACTA ENDOCRINOLOGICA, 1983, 104 (03): : 257 - 260
  • [29] Preliminary in vitro approach to evaluate the drug-drug interaction potential of EST73502, a dual μ-opioid receptor partial agonist and σ1 receptor antagonist
    Ayet, Eva
    Yeste, Sandra
    Reinoso, Raquel F.
    Pretel, Maria Jose
    Balada, Ariadna
    Serafini, Maria Teresa
    XENOBIOTICA, 2021, 51 (05) : 501 - 512
  • [30] Computational docking and opioidmimetics:: Investigation of δ-opioid agonist and antagonist receptor interactions.
    Bryant, S
    Lazarus, LH
    Salvadori, S
    Guerrini, R
    Balboni, G
    Jinsmaa, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U461 - U461
12345